Literature DB >> 17618663

Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.

Anna Kawiak1, Jacek Piosik, Grzegorz Stasilojc, Anna Gwizdek-Wisniewska, Lukasz Marczak, Maciej Stobiecki, Jacek Bigda, Ewa Lojkowska.   

Abstract

Reactive oxygen species (ROS) have been recognized as key molecules, which can selectively modify proteins and therefore regulate cellular signalling including apoptosis. Plumbagin, a naphthoquinone exhibiting antitumor activity, is known to generate ROS and has been found to inhibit the activity of topoisomerase II (Topo II) through the stabilization of the Topo II-DNA cleavable complex. The objective of this research was to clarify the role of ROS and Topo II inhibition in the induction of apoptosis mediated by plumbagin. As determined by the comet assay, plumbagin induced DNA cleavage in HL-60 cells, whereas in a cell line with reduced Topo II activity-HL-60/MX2, the level of DNA damage was significantly decreased. The onset of DNA strand break formation in HL-60 cells was delayed in comparison with the generation of intracellular ROS. In HL-60/MX2 cells, ROS were generated at a similar rate, whereas a significant reduction in the level of DNA damage was detected. The pretreatment of cells with N-acetylcysteine (NAC) attenuated plumbagin-induced DNA damage, pointing out to the involvement of ROS generation in cleavable complex formation. These results suggest that plumbagin-induced ROS does not directly damage DNA but requires the involvement of Topo II. Furthermore, experiments carried out using light spectroscopy indicated no direct interactions between plumbagin and DNA. The induction of apoptosis was significantly delayed in HL-60/MX2 cells indicating the involvement of Topo II inhibition in plumbagin-mediated apoptosis. Thus, these findings strongly suggest ROS-mediated inhibition of Topo II as an important mechanism contributing to the apoptosis-inducing properties of plumbagin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618663     DOI: 10.1016/j.taap.2007.05.018

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

1.  Plumbagin promotes the generation of astrocytes from rat spinal cord neural progenitors via activation of the transcription factor Stat3.

Authors:  Yongquan Luo; Mohamed R Mughal; Tae-Gen Son Xin Ouyang; Haiyang Jiang; Weiming Luo; Qian-Sheng Yu; Nigel H Greig; Mark P Mattson
Journal:  J Neurochem       Date:  2010-12       Impact factor: 5.372

2.  Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas.

Authors:  Jordan M Sand; Bilal Bin Hafeez; Mohammad Sarwar Jamal; Olya Witkowsky; Emily M Siebers; Joseph Fischer; Ajit K Verma
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

3.  Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species.

Authors:  Rachel Sensenig; Sameer Kalghatgi; Ekaterina Cerchar; Gregory Fridman; Alexey Shereshevsky; Behzad Torabi; Krishna Priya Arjunan; Erica Podolsky; Alexander Fridman; Gary Friedman; Jane Azizkhan-Clifford; Ari D Brooks
Journal:  Ann Biomed Eng       Date:  2010-10-29       Impact factor: 3.934

4.  Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression.

Authors:  Jingping Sun; Robert J McKallip
Journal:  Leuk Res       Date:  2011-07-08       Impact factor: 3.156

5.  Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols.

Authors:  Rahul Checker; Deepak Sharma; Santosh K Sandur; G Subrahmanyam; Sunil Krishnan; T B Poduval; K B Sainis
Journal:  J Cell Biochem       Date:  2010-08-01       Impact factor: 4.429

6.  Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells.

Authors:  Jiawen Li; Qin Shen; Rui Peng; Rongyi Chen; Ping Jiang; Yanqiu Li; Li Zhang; Jingjing Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

Review 7.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

8.  5-hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization.

Authors:  Santosh K Sandur; Manoj K Pandey; Bokyung Sung; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

9.  Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.

Authors:  Moammir H Aziz; Nancy E Dreckschmidt; Ajit K Verma
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

10.  The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation.

Authors:  Ju-Hee Lee; Ji-Hyun Yeon; Hanna Kim; Whijae Roh; Jeiwook Chae; Han-Oh Park; Dong-Myung Kim
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.